← Back to Search

Other

BTL-785-7 for Wrinkles

N/A
Waitlist Available
Research Sponsored by BTL Industries Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 months
Awards & highlights

Study Summary

This trial will study how well a new device, the BTL-785-7 applicator, works to improve facial wrinkles and appearance.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Histological examination
Secondary outcome measures
Evaluation of Overall Facial Appearance According to GAIS
Evaluation of Wrinkle Severity
Subject Satisfaction
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: BTL-785-7 TreatmentExperimental Treatment1 Intervention
Subjects will be enrolled for an active treatment with BTL-785F device (BTL-785-7 applicator) for non-invasive facial rejuvenation.
Group II: ControlActive Control1 Intervention
One subject will serve as a control.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BTL-785-7
2023
N/A
~110

Find a Location

Who is running the clinical trial?

BTL Industries Ltd.Lead Sponsor
51 Previous Clinical Trials
1,795 Total Patients Enrolled
12 Trials studying Wrinkles
370 Patients Enrolled for Wrinkles

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Apr 2025